Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis
Animal Models and Experimental Medicine · 2024
DOI: 10.1002/ame2.12337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Donglin Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, C…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Rats, Sprague-Dawley, Bacillus subtilis, Intestinal Mucosa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province of China.
Abstract (Originalsprache)
Background
Nonalcoholic steatohepatitis (NASH) is characterized by liver steatosis, inflammation, and even fibrosis. NASH is likely to develop into cirrhosis and liver cancer, the major causes of liver related deaths. We aimed to study the effect of probiotics on NASH via the gut‐liver axis.
Methods
Thirty male Sprague–Dawley rats were divided into three groups. A control group of 10 rats was fed on a standard chow for 16 weeks. Twenty rats fed on a high‐fat diet for 8 weeks were separated to two groups: a model group (10 rats) fed on vehicle for 8 weeks and a treatment group (10 rats) supplemented with binary Bacillus subtilis for 8 weeks. Hepatic expression of IL‐6 and TNF‐ɑ and ileum expression of IL‐17 and occludin were measured.
Results
The high‐fat diet caused inflammation of the liver and ileum in rats. Binary Bacillus subtilis treatment reduces liver inflammation through the intestinal liver axis. Increased levels of IL‐6 and TNF‐α were detected in rats fed a high‐fat diet, which were reduced to lower levels after treatment with binary Bacillus subtilis . In rats on the high‐fat diet, elevated IL‐17 levels and decreased occludin levels were observed. Treatment with Bacillus subtilis reduced IL‐17 levels and restored the expression of occludin.
Conclusion
Binary Bacillus subtilis has a beneficial effect on liver inflammation and intestinal damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
ORCID-Profile: Pengguo Chen
Förderung
- Natural Science Foundation of Jiangxi Province of China
Zitieren
APA
Liu, D., & Chen, P. (2024). Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12337
Vancouver
Liu D, Chen P. Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12337
BibTeX
@article{Liu2024,
author = {Liu, Donglin and Chen, Pengguo},
title = {Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis},
journal = {Animal Models and Experimental Medicine},
year = {2024},
doi = {10.1002/ame2.12337}
}
EUVIMED